ProCE Banner Activity

Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Patient Cases

Slideset

Download these slides to see how experts discuss the use of SGLT2 inhibitors, GLP-1 receptor agonists, and GIP/GLP-1 coagonists in patients with type 2 diabetes and obesity, including a focus on complex patients with advanced comorbidities.

Released: December 05, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Endocrine Society

ProCE Banner